CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-23 | Morrison Briggs Director | Grant or award · Stock Option (right to buy) | +12,923 | 12,923 | ||
| 2019-05-23 | Ratcliffe Liam Director | Grant or award · Stock Option (right to buy) | +12,923 | 12,923 | ||
| 2019-05-23 | Loven Jakob Director | Grant or award · Stock Option (right to buy) | +12,923 | 12,923 | ||
| 2019-05-23 | Margus Bradley Albert Director | Grant or award · Stock Option (right to buy) | +12,923 | 12,923 | ||
| 2019-05-23 | PARMAR KUSH Director | Grant or award · Stock Option (right to buy) | +12,923 | 12,923 | ||
| 2019-03-29 | Taylor Ian Chief Scientific Officer | Purchase | +1,000 | $14.66 | $15K | 85,496 |
| 2019-03-28 | 5AM VENTURES III, L.P. 10% owner | Sale | −352,056 | $14.16 | $5.0M | 4,512,136 |
| 2019-03-28 | 5AM VENTURES III, L.P. 10% owner | Sale | −9,073 | $14.16 | $128K | 116,287 |
| 2019-03-28 | SHANNON TIMOTHY M Director | Purchase | +3,500 | $14.69 | $51K | 58,898 |
| 2019-03-01 | Houston John G President and CEO | Grant or award · Restricted Stock Units | +70,042 | 70,042 | ||
| 2019-03-01 | Houston John G President and CEO | Grant or award · Stock Option (right to buy) | +254,597 | 254,597 | ||
| 2019-03-01 | Taylor Ian Senior Vice President, Biology | Grant or award · Restricted Stock Units | +10,742 | 10,742 | ||
| 2019-03-01 | Taylor Ian Senior Vice President, Biology | Grant or award · Stock Option (right to buy) | +65,427 | 65,427 | ||
| 2019-03-01 | Crew Andrew | Grant or award · Restricted Stock Units | +10,734 | 10,734 | ||
| 2019-03-01 | Crew Andrew | Grant or award · Stock Option (right to buy) | +60,745 | 60,745 | ||
| 2019-03-01 | Crew Andrew | Grant or award · Restricted Stock Units | +776 | 776 | ||
| 2019-03-01 | Crew Andrew | Grant or award · Stock Option (right to buy) | +1,924 | 1,924 | ||
| 2019-03-01 | Cassidy Sean A Chief Financial Officer | Grant or award · Restricted Stock Units | +19,165 | 19,165 | ||
| 2019-03-01 | Cassidy Sean A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +87,752 | 87,752 | ||
| 2019-01-18 | Houston John G President and CEO | Grant or award · Stock Option (right to buy) | +13,360 | 13,360 |
Page 27 of 32 · 628 trades